ROCO
6543
Market cap42mUSD
Nov 12, Last price
29.40TWD
Name
Perfect Medical Industry Co Ltd
Chart & Performance
P/E
15.06
P/S
1.80
EPS
1.95
Div Yield, %
4.21%
Shrs. gr., 5y
4.42%
Rev. gr., 5y
1.95%
Revenues
744m
+1.37%
Net income
89m
+122.31%
CFO
144m
-4.22%
Dividend
Oct 09, 20240.63 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally. It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes. The company also offers its products under the PF brand in Asia, Africa, Europe, and South America. Perfect Medical Industry Co., Ltd. was founded in 1989 and is headquartered in Changhua, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||